Crisanto Reyes
Internal Medicine · Milford, ILNPI 1154461978
Payments from drug & device makers
Across 89 payments — averaging $17.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$280
- Bayer$209
- Nestle Healthcare Nutrition Inc.$157
- Johnson & Johnson$124
- AbbVie$122
- Boehringer Ingelheim$121
- plus $575 from 17 others
What the payments were for
- Food & beverage$1,587100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 15 | $280 |
| Bayer | 10 | $209 |
| Nestle Healthcare Nutrition Inc. | 9 | $157 |
| Johnson & Johnson | 4 | $124 |
| AbbVie(2 entities) | 7 | $122 |
| Boehringer Ingelheim | 8 | $121 |
| Novo Nordisk | 8 | $115 |
| Novartis | 5 | $87 |
| GSK | 5 | $80 |
| Lilly USA, LLC | 4 | $61 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $36 |
| Exact Sciences | 1 | $27 |
| Paratek Pharmaceuticals, Inc. | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Boston Scientific | 1 | $17 |
| Amgen | 1 | $16 |
| Dexcom, Inc. | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| Aimmune Therapeutics, Inc. | 1 | $15 |
| Pulmonx Corporation | 1 | $14 |
| Merck | 1 | $13 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| Itamar Medical Inc | 1 | $11 |
How this compares
$1,587 in reported general payments places this provider in the 80th percentile of 5,182 internal medicine providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 134 | $77,542 |
| EliquisApixaban | 86 | $45,979 |
| JanuviaSitagliptin Phosphate | 53 | $25,403 |
| XareltoRivaroxaban | 34 | $21,517 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 26 | $18,450 |
| TrulicityDulaglutide | 15 | $15,591 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 45 | $13,842 |
| FarxigaDapagliflozin Propanediol | 13 | $13,631 |
| TradjentaLinagliptin | 15 | $9,036 |
| Incruse ElliptaUmeclidinium Bromide | 24 | $9,011 |
| AbrysvoRsv Vacc, Pref A And Pref B/Pf | 23 | $7,082 |
| Breo ElliptaFluticasone/Vilanterol | 14 | $5,729 |
| VascepaIcosapent Ethyl | 24 | $5,178 |
| Potassium Chloride | 191 | $5,048 |
| Aripiprazole | 40 | $4,696 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta | $121 | $86,578149 claims |
| GSKTrelegy Ellipta, Incruse Ellipta, Breo Ellipta, Shingrix | $80 | $37,15983 claims |
| MerckJanuvia | $13 | $25,40353 claims |
| Johnson & JohnsonXarelto | $124 | $21,51734 claims |
| Lilly USA, LLCTrulicity | $61 | $15,59115 claims |
| AstraZenecaFarxiga | $280 | $13,63113 claims |
| Aimmune Therapeutics, Inc.Zenpep | $15 | $4,50112 claims |
| AbbVieSynthroid | $122 | $3,13731 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 5,182 internal medicine providers in Illinois.
Other internal medicine in Milford
- Dennis LevinsonChicago$25.3M
- Mary BrownRockford$16M
- Andrew BartlettChampaign$4.1M
- Danny SugimotoChicago$4M
- Peter O DonnellChicago$3.9M
- Daniel CatenacciChicago$3.5M
- Jeffrey GeohasEvanston$2.3M
- Patricia WalshChicago$2.1M
- Merle DiamondChicago$1.7M
- Yoko MomoyamaLombard$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.